Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
IOL CHEMICALS & PHARM. TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
TEVA PHARMA Dec-13 |
IOL CHEMICALS & PHARM./ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 3,486 | - | |
Low | Rs | 272 | 3,028 | - | |
Sales per share (Unadj.) | Rs | 377.6 | 2,000.5 | - | |
Earnings per share (Unadj.) | Rs | 23.7 | 125.0 | - | |
Cash flow per share (Unadj.) | Rs | 31.6 | 286.7 | - | |
Dividends per share (Unadj.) | Rs | 4.00 | 109.40 | - | |
Avg Dividend yield | % | 1.0 | 3.4 | 29.4% | |
Book value per share (Unadj.) | Rs | 256.8 | 2,222.2 | - | |
Shares outstanding (eoy) | m | 58.71 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.6 | 65.8% | |
Avg P/E ratio | x | 17.1 | 26.1 | 65.5% | |
P/CF ratio (eoy) | x | 12.8 | 11.4 | 112.8% | |
Price / Book Value ratio | x | 1.6 | 1.5 | 107.4% | |
Dividend payout | % | 16.9 | 87.5 | 19.3% | |
Avg Mkt Cap | Rs m | 23,743 | 2,761,843 | 0.9% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 1,682 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,744.4 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,357.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,696,422 | 1.3% | |
Other income | Rs m | 256 | 0 | - | |
Total revenues | Rs m | 22,427 | 1,696,422 | 1.3% | |
Gross profit | Rs m | 2,257 | 464,566 | 0.5% | |
Depreciation | Rs m | 462 | 137,123 | 0.3% | |
Interest | Rs m | 165 | 33,320 | 0.5% | |
Profit before tax | Rs m | 1,887 | 294,122 | 0.6% | |
Minority Interest | Rs m | 0 | 1,336 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -193,075 | -0.0% | |
Tax | Rs m | 495 | -3,591 | -13.8% | |
Profit after tax | Rs m | 1,391 | 105,974 | 1.3% | |
Gross profit margin | % | 10.2 | 27.4 | 37.2% | |
Effective tax rate | % | 26.2 | -1.2 | -2,149.6% | |
Net profit margin | % | 6.3 | 6.2 | 100.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,145,757 | 0.8% | |
Current liabilities | Rs m | 5,025 | 999,197 | 0.5% | |
Net working cap to sales | % | 20.9 | 8.6 | 242.3% | |
Current ratio | x | 1.9 | 1.1 | 167.8% | |
Inventory Days | Days | 43 | 91 | 47.7% | |
Debtors Days | Days | 8 | 96 | 8.7% | |
Net fixed assets | Rs m | 11,017 | 554,089 | 2.0% | |
Share capital | Rs m | 587 | 4,176 | 14.1% | |
Net worth | Rs m | 15,077 | 1,884,403 | 0.8% | |
Long term debt | Rs m | 0 | 867,418 | 0.0% | |
Total assets | Rs m | 20,684 | 3,876,868 | 0.5% | |
Interest coverage | x | 12.5 | 9.8 | 126.7% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.4 | 245.0% | |
Return on assets | % | 7.5 | 3.6 | 209.4% | |
Return on equity | % | 9.2 | 5.6 | 164.1% | |
Return on capital | % | 13.6 | 4.9 | 275.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 270,322 | 0.5% | |
From Investments | Rs m | -1,200 | -95,786 | 1.3% | |
From Financial Activity | Rs m | -41 | -324,269 | 0.0% | |
Net Cashflow | Rs m | -18 | -149,733 | 0.0% |
Compare IOL CHEMICALS & PHARM. With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare IOL CHEMICALS & PHARM. With: NUTRAPLUS PR IND. SWIFT DISHMAN CARBOGEN AMCIS LINK PHARMA ROOPA INDUSTRIES
It was indeed a volatile trading session for Indian share markets yesterday.